Skip to main content
. Author manuscript; available in PMC: 2017 Oct 24.
Published in final edited form as: Eur J Cardiovasc Prev Rehabil. 2009 Feb;16(1):16–20. doi: 10.1097/HJR.0b013e32830aba5c

Table 2.

Odds ratios (ORs) and 95% confidence intervals (CIs) of CVD mortality by levels of serum GGT: the Minnesota Heart Survey

Baseline serum GGT level (U/l)
P trend
<18 18 to <25 25 to ≤ 50 >50
All ages (years)
 Cases/controls 33/75 43/88 36/68 26/18
 Odds ratio (95% CI)
  Model 1a 1.00 1.09 (0.62–1.90) 1.25 (0.70–2.23) 3.59 (1.70–7.60) <0.01
  Model 2b 1.00 1.01 (0.57–1.80) 1.08 (0.59–1.98) 2.68 (1.22–5.88)   0.05
  Model 3c 1.00   0.91 (0.50–1.65)   0.88 (0.47–1.66) 1.88 (0.82–4.33)   0.37
Age less than 70 years
 Cases/controls 7/38 14/40 20/34 16/12
 Odds ratio (95% CI)
  Model 1a 1.00 2.28 (0.79–6.56) 3.87 (1.37–10.9) 9.07 (2.80–29.4) <0.01
  Model 2b 1.00 2.10 (0.68–6.45) 3.64 (1.18–11.2) 6.70 (1.83–24.6) <0.01
  Model 3c 1.00 2.17 (0.68–6.97) 3.54 (1.07–11.7) 4.69 (1.16–18.9)   0.02
Age more than or equal to 70 years
 Cases/controls
 Odds ratio (95% CI) 26/37 28/48 16/34 10/6
  Model 1a 1.00   0.81 (0.40–1.64)   0.68 (0.31–1.49) 2.34 (0.75–7.30)   0.67
  Model 2b 1.00   0.85 (0.42–1.75)   0.68 (0.31–1.51) 2.35 (0.72–7.66)   0.72
  Model 3c 1.00   0.76 (0.35–1.62)   0.51 (0.22–1.20) 1.63 (0.45–5.82)   0.63
a

Adjusted for matching factors age (continuous) and sex.

b

Adjusted for matching factors age (continuous) and sex, BMI (continuous), current cigarette smoking, alcohol use (continuous), physical activity (continuous).

c

Adjusted as in model 2 and serum total cholesterol (continuous), serum HDL cholesterol (continuous), systolic blood pressure (continuous), and nonfasting serum glucose (continuous). CVD, cardiovascular diseases; GGT, gamma-glutamyltransferase; HDL, high-density lipoprotein.